Sickle cell disease in North Europe

References

• Serjeant G. R. Recent advances in sickle cell disease. Recent advances in paediatrics, T. J David. Churchill Livingstone, Edinburgh 1994; 141–54
   Google Scholar
• Davies S. C., Gilmore A. The role of hydroxyurea in the management of sickle cell disease. Blood Rev 2003; 17: 99–109
   PubMed Web of Science ®Google Scholar
• Serjeant G. R. Sickle‐cell disease. Lancet 1997; 350: 725–30
   PubMed Web of Science ®Google Scholar
• Platt O. S., Brambilla D. J., Rosse W. F., Milner P. F., Castro O., Steinberg M. H., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639–44
   PubMed Web of Science ®Google Scholar
• Wierenga K. J. J., Hambleton I. R., Lewis N. A. Survival estimates for patients with homozygous sickle‐cell disease in Jamaica: a clinic‐based population study. Lancet 2001; 357: 680–3
   PubMed Web of Science ®Google Scholar
• Gaston M., Verter J. I., Joel I., Woods G., Pegelow C., Kelleher J., et al. Prophylaxis with oral penicillin in children with sickle cell anaemia: a randomized trial. N Engl J Med 1986; 314: 1594–9
   Web of Science ®Google Scholar
• Lees C. M., Davies S. C., Dezateux C. Neonatal screening for sickle cell disease. The Cochrane Database of Systematic Reviews. 2000, Issue 1
   Google Scholar
• Riddington C., Owusu‐Ofori S. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease. The Cochrane Database of Systematic Reviews. 2002(3), CD003427
   Google Scholar
• Davies G. E., Riddington C., Lottenberg R., Dower N. Pneumococcal vaccines for sickle cell disease in children and adults. The Cochrane Database of Systematic Reviews. 2004; 3
   Google Scholar
• Lee A., Thomas P., Cupidore L., Serjeant B., Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. Br Med J 1995; 311: 1600–2
   PubMed Web of Science ®Google Scholar
• Zeuner D., Ades A. E., Karnon K., Brown J., Dezateux C., Anionwu E. Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis. Health Technol Assess 1999; 3
   PubMedGoogle Scholar
• Davies S. C., Cronin E., Gill M., Greengross P., Hickman M., Normand C. Screening for sickle cell disease and Thalassaemia: a systematic review with supplementary research (2000). Health Technology Assessment 2000; 4
   PubMedGoogle Scholar
• Davies S. C., Oni L. Management of patients with sickle cell disease. Br Med J 1997; 315: 656–60
   PubMed Web of Science ®Google Scholar
• Rees D. C., Olujohengbe A. D., Parker N. E., Stephens A. D., Telfer P., Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003; 120: 744–52
   PubMed Web of Science ®Google Scholar
• Benjamin L. J., Swinson G. I., Nagel R. I. Sickle cell anaemia day hospital: an approach for the management of uncomplicated painful crises. Blood 2000; 95: 1130–6
   PubMed Web of Science ®Google Scholar
• Ohene‐Frempong K., Weiner S. J., Sleeper L. A., Miller S. T., Embury S., Moohr J. W., et al. Cerebrovascular disease in sickle cell disease: rates and risk factors. Blood 1998; 91: 288–94
   PubMed Web of Science ®Google Scholar
• Charache S., Terrin M. L., Moore R. D., Dover G. J., Benton F. B., Wadawiw M., et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anaemia. N Engl J Med 1995; 332: 1317–22
   PubMed Web of Science ®Google Scholar
• Pegelow C. H., Adams R. J., McKie V., Abboud M., Berman B., Miller S. T. Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr 1995; 126: 869–9
   Web of Science ®Google Scholar
• Wang W. C., Kovnar E. H., Tonkin I. L., Mulhern R. K., Langston J. W., Day S. W., et al. High risk of recurrent stroke after discontinuation of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991; 118: 377–82
   PubMed Web of Science ®Google Scholar
• Adams R. J., McKie V. C., Hsu L., Files B., Vichinsky E., Pegelow C., et al. Prevention of a first stroke by transfusions in children with sickle cell anaemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998; 339: 5–11
   PubMed Web of Science ®Google Scholar
• Miller S. T., Macklin E. A., Pegelow C. H., Kinnay T. R., Sleeper L. A., Bellow A., et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. 139: 385–90, 200l
   Google Scholar
• Charache S., Scott J. C., Charache P. Acute chest syndrome in adults with sickle cell anaemia. Arch Intern Med 1979; 138: 67–9
   Google Scholar
• Vichinsky E. P., Neumayr L. D., Earles A. N., Williams R., Lennette E. T., Dean D., et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. N Engl J Med 2000; 342: 1855–65
   PubMed Web of Science ®Google Scholar
• Emre U., Miller St., Gutieriez M., Steiner P., Rao S. P., Rao M. Effect of transfusion in acute chest syndrome of sickle cell disease. J Pediatr 1995; 127: 901–4
   PubMed Web of Science ®Google Scholar
• Bellet P. S., Kalinyak K. A., Shukla R., Gelfand M., Rucknagel D. L. Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. N Engl J Med 1995; 333: 699–703
   PubMed Web of Science ®Google Scholar
• Knight‐Madden J. M., Hambleton I. R. Inhaled bronchodilators for acute chest syndrome in people with sickle cell disease. The Cochrane Database of Systematic Reviews. 2003, Issue 3. Art. no. CD 003733. DOI: 10.1002/14651858
   Google Scholar
• Charache S., Lubin B., Reid C. D. Stroke. Management and therapy of sickle cell disease, 3rd edn, S Charache, B Lubin, C. D Reid. US Department of Health, Washington, DC 1995; 53–8
   Google Scholar
• Powars D., Weidman J. A., Odom‐Maryon T., Niland J. C., Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine 1988; 67: 66–76
   PubMed Web of Science ®Google Scholar
• Gladwin M. T., Sachdev V., Jison M. L., Shizukuda Y., Plehn J. F., Minter K., et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350: 886–95
   PubMed Web of Science ®Google Scholar
• Machado R. F., Gladwin M. T. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension. Br J Haematol 2005; 129: 449–64
   PubMed Web of Science ®Google Scholar
• Machado R. F., Martyr S., Kato G. J., Barst R. J., Anthi A., Robinson M. R., et al. Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Br J Haematol 2005
   Web of Science ®Google Scholar
• Mantadakis E., Ewalt D. H., Cavender J. D., Rogers Z. R., Buchanan G. R. Outpatient penile aspiration and epinephrine irrigation for young patients with sickle cell anaemia and prolonged priapism. Blood 2000; 95: 78–82
   PubMed Web of Science ®Google Scholar
• Gbadoe A. D., Atakouma Y., Kusiaku K., Assimadi J. K. Management of sickle cell priapism with etilefrine. Arch Dis Child 2001; 85: 52–3
   PubMed Web of Science ®Google Scholar
• Ware H. E., Brooks A. P., Toye R., Berney S. I. Sickle cell disease and silent avascular necrosis of the hip. J Bone Joint Surg 1991; 73: 947–49
   Web of Science ®Google Scholar
• Powars D. R., Hiti A., Ramicone E., Johnson C., Chan L. Outcome in hemoglobin SC disease: a four‐decade observational study of clinical, hematologic and genetic factors. Am J Hematol 2002; 70: 206–15
   PubMed Web of Science ®Google Scholar
• Claster S., Vichinsky E. P. Managing sickle cell disease. B Med J 2003; 327: 1151–5
   PubMed Web of Science ®Google Scholar
• Steinberg M. H., Barton F., Castro O., Pegelow C. H., Ballas S. K., Kutler A., et al. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anaemia: risks and benefits of up to 9 years of treatment. J Am Med Assoc 2003; 289: 1645–51
   PubMed Web of Science ®Google Scholar
• Ferster A., Vermylen C., Cornu G., Buyse M., Corazza F., Devalck C., et al. Hydroxyurea for treatment of severe sickle cell anaemia: a pediatric clinical trial. Blood 1996; 88: 1960–4
   PubMed Web of Science ®Google Scholar
• Ferster A., Tahriri P., Vermylen C., Sturbis G., Corazza F., Fondu P., et al. Five years of experience with hydroxyurea in children and adults with sickle cell disease. Blood 2001; 97: 3628–32
   PubMed Web of Science ®Google Scholar
• Diav‐Citrin O., Hunnisett L., Sher G. D., Koren G. Hydroxyurea use during pregnancy: case report in sickle cell disease and review of the literature. Am J Hematol 1999; 60: 148–50
   PubMed Web of Science ®Google Scholar
• Horiuchi K., Golden J. A., Das S. K., Scully M., Lian L., Ohene‐Frempong K., et al. Adverse effects of hydroxyurea on growth and development of young mice. Blood 1998; 92(Suppl 1)160a
   PubMed Web of Science ®Google Scholar
• Hankins J. S., Ware R. E., Rogers Z. R., Wynn L. W., Lane P. A., Scott J. P., et al. Long‐term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood 2005
   PubMed Web of Science ®Google Scholar
• Miller D. M., Winslow R. M., Klein H. G., Wilson K. C., Brown F. L., Statham N. J. Improved exercise performance after exchange transfusion in subjects with sickle cell anaemia. Blood 1980; 56: 1127–31
   PubMed Web of Science ®Google Scholar
• Riddington C., Williamson L. Preoperative blood transfusions for sickle cell disease. The Cochrane Database of Systematic Reviews. 2004, CD003149–CD00493X
   Google Scholar
• Davies S. C., McWilliam A. C., Hewitt P. E., Devenish A., Brozovic M. Red cell alloimmunization in sickle cell disease. Br J Haematol 1986; 63: 241–5
   PubMed Web of Science ®Google Scholar
• Vichinsky E. P., Earles A., Johnson R. A., Hoag M. S., Williams A., Lubin B. Alloimmunization in sickle cell anaemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322: 1617–21
   PubMed Web of Science ®Google Scholar
• Rosse W. F., Gallagher D., Kinney, Castro O., Dosik H., Moohr J., et al. Transfusion and alloimmunization in sickle cell disease: The Cooperative Study of Sickle Cell Disease. Blood 1990; 76: 1431–7
   PubMed Web of Science ®Google Scholar
• Cullis J. O., Win N., Dudley J. M., Kaye T. Post‐transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction. Vox Sang 1995; 69: 355–7
   PubMed Web of Science ®Google Scholar
• Koshy M., Burd L., Wallace D., Moawad A., Baron J. Prophylactic red cell transfusions in patients with sickle cell disease: a randomized cooperative study. N Engl J Med 1998; 319: 1447–52
   Web of Science ®Google Scholar
• Vichinsky E. P., Haberkan C. M., Neumayr L., Earles A. N., Black D., Koshy M., et al. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. N Engl J Med 1995; 333: 206–13
   PubMed Web of Science ®Google Scholar
• Hatley R. M., Christ D., Howell C. F., Herline A. J., Gadacz T. R. Laparoscopic cholecystectomy in children with sickle cell disease. Am Surg 1995; 61: 169–71
   PubMed Web of Science ®Google Scholar
• Roberts‐Harewood M., Nokes T. J. C., Taylor P. C., Davies S. C. Adenotonsillectomy in sickle cell disease: is routine transfusion necessary?. Br J Haematol 1997; 97(Suppl 1)75
   Google Scholar
• Johnson F. L., Look A. T., Gockerman J., Ruggiero M. R., Dalla‐Pozza L., Billings F. T 3rd. Bone marrow transplantation in a patient with sickle cell anaemia. N Engl J Med 1984; 311: 780–3
   PubMed Web of Science ®Google Scholar
• Hoppe C. C., Walters M. C. Bone marrow transplantation in sickle cell anaemia. Curr Opin Oncol 2001; 13: 85–90
   PubMed Web of Science ®Google Scholar
• Bernaudin F., Souillet G., Vannier J. P., Vilmer E., Michel G., Lutz P., et al. Report of the French experience concerning 26 children transplanted for severe sickle cell disease. Bone Marrow Transpl 1997; 19(Suppl 2)112
   Google Scholar
• Vermylen C., Cornu G., Ferster A., Brichard B., Ninane J., Ferrant A. Haematopoietic stem cell transplantaion for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transpl 1998; 22: 1–16
   PubMed Web of Science ®Google Scholar
• Walters M. C., Storb R., Patience M., Leisenring W., Taylor T., Sanders J. E., et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Blood 2000; 95: 1918–24
   PubMed Web of Science ®Google Scholar